Celia Raimondi

Celia Raimondi has a diverse work experience in the scientific research field. Celia is currently working at Evonetix Ltd as a Senior Scientist since 2022. Prior to that, they were a Senior Scientist at Wren Therapeutics Ltd from 2020 to 2022. At Wren Therapeutics, they led the Parkinson drug discovery project and managed a team of scientists. Additionally, they served as a Scientist at Wren Therapeutics from 2020 to 2022. Before joining Wren Therapeutics, Celia worked as a Postdoctoral Research Scientist at The Babraham Institute from 2019 to 2020 and at Institut Pasteur from 2017 to 2018.

Celia Raimondi has a strong education history in the field of molecular genetics. Celia completed their Bachelor's degree in Biology, General at Université Côte d'Azur from 2008 to 2011. Celia then pursued their Master's degree in Genetics at Pierre and Marie Curie University from 2011 to 2013. Following their master's, they obtained a Doctor of Philosophy - PhD degree in Molecular Genetics from both Pasteur Institute and Pierre and Marie Curie University, where they studied from 2013 to 2017.